PHARMACON
Vol. 11 No. 3 (2022): PHARMACON

Review Virus Chikungunya

Grenshannya Anasthasya Pua (Sam Ratulangi University)
Fatimawali Fatimawali (Unknown)
Irma Antasionasti (Unknown)

Article Info

Publish Date
07 Dec 2022

Abstract

Chikungunya is a virus belonging to the family Togaviridae and genus Alphavirus which was first isolated in Tanzania in 1953. This virus transmission by mosquito vectors, namely Aedes aygepti and Aedes albopictus. Indonesia itself is included as the country that has the largest burden of Chikungunya in Southeast Asia. Symptoms caused by this viral infection are severe enough to cause temporary paralysis and prolonged joint pain. Chikungunya virus drugs and vaccines are not yet officially available and are licensed only in the form of symptomatic treatment that can be given to reduce symptoms. Research and development of Chikungunya virus treatment and vaccines are currently being developed to control the spread of the Chikungunya virus. 

Copyrights © 2022




Citation Download
RIS
EndNote, Reference Manager, ProCite
BibTex
Latex, Jabref
Original Source
Download Original
Google Scholar
Check in Google Scholar
Journal Info
PHARMACON
Website

Abbrev

pharmacon

Publisher

Universitas Sam Ratulangi

Subject

Medicine & Pharmacology

Description

Pharmacon is the journal published by Pharmacy Study Program, Faculty of Mathematics and Natural Sciences, Sam Ratulangi University, Indonesia (P-ISSN: 2302-2493 E-ISSN: 2721-4923). Pharmacon was established in 2012 and published four times a year. Pharmacon is an open access journal and has been ...